Global Medical Radioisotopes Market Growth (Status and Outlook) 2023-2029

Global Medical Radioisotopes Market Growth (Status and Outlook) 2023-2029

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
LPI (LP Information)' newest research report, the “Medical Radioisotopes Industry Forecast” looks at past sales and reviews total world Medical Radioisotopes sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Radioisotopes sales for 2023 through 2029. With Medical Radioisotopes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Radioisotopes industry.
This Insight Report provides a comprehensive analysis of the global Medical Radioisotopes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Radioisotopes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Radioisotopes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Radioisotopes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Radioisotopes.
The global Medical Radioisotopes market size is projected to grow from US$ 635.4 million in 2022 to US$ 862.4 million in 2029; it is expected to grow at a CAGR of 4.5% from 2023 to 2029.
Global key medical radioisotopes manufacturers include NRG, IRE etc.The top 2 companies hold a share about 40%.Americas is the largest market, with a share about 45%, followed by Europe and APAC with the share about 25% and 23%.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Radioisotopes market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Segmentation by application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom

Please note: The report will take approximately 2 business days to prepare and deliver.